 Shares of Fresenius Medical Care tumbled 13.7 in premarket trading on Thursday after telling investors to expect lower-than-expected revenue and net income in the second half of the year. The company, which provides kidney dialysis services, cited concerns about wage inflation and staff shortages in North America, higher inflation, and supply-chain disruptions. 